Il Dong Holdings Co., Ltd. (000230) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Il Dong Holdings Co., Ltd. (000230:KRX), powered by AI.

Current Price
₩7,300
P/E Ratio
7.7
Market Cap
84.2B
Sector
Healthcare
What is the Il Dong Holdings Co., Ltd. stock price forecast?

Il Dong Holdings Co., Ltd. is currently trading at ₩7,300. View real-time AI analysis on Alpha Lenz.

What is Il Dong Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Il Dong Holdings Co., Ltd. on Alpha Lenz.

What is Il Dong Holdings Co., Ltd.'s P/E ratio?

Il Dong Holdings Co., Ltd.'s P/E ratio is 7.7.

Il Dong Holdings Co., Ltd.

KRX · 000230
₩7,300+80(+1.11%)Market closedKRX regular session 09:00–15:30 KST
Ask about Il Dong Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Il Dong Holdings Co., Ltd. trades at a P/E of 7.7 (undervalued) with modest ROE of 7.2%.

Ask for details

Company Overview

Il Dong Holdings Co., Ltd. is a multifaceted corporation primarily engaged in the pharmaceutical and healthcare industry in South Korea. Its core business involves the management and investment in subsidiaries that develop and manufacture pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. The company's influence extends to biotechnology, where it invests in research and development to bolster innovations in the medical field. Il Dong Holdings also plays a significant role in the consumer health sector, offering a range of nutraceuticals and wellness products that cater to both local and international markets. As a holding company, it continuously seeks opportunities for growth and diversification within the healthcare domain to maintain a robust presence in the competitive global market. Through strategic management and expansion of its business portfolio, Il Dong Holdings contributes significantly to advancements in health-related solutions, impacting hospitals, pharmacies, and consumers alike. With its headquarters in South Korea, the company integrates its resources and expertise to meet the dynamic demands of the pharmaceutical and healthcare industries effectively.

CEO박대창
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees72

Company Statistics

FY 2025

Profile

₩84,244,920,000Market Cap
₩590,889,546,400Revenue
11.54MShares Out
72Employees

Margins

38.10%Gross
11.83%EBITDA
2.56%Operating
5.13%Pre-Tax
3.65%Net

Valuation

7.71P/E
0.50P/B
0.14EV/Sales
5.49EV/EBITDA
9.39P/FCF

Growth (CAGR)

-4.36%Rev 3Yr
-0.19%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

2.60%ROA
7.22%ROE
6.46%ROIC

Financial Health

₩76,613,313,500Cash & Cash Equivalents
₩380,668,273,370Net Debt
132.32%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Il Dong Holdings Co., Ltd. (ticker: 000230) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 72 employees. Market cap is $84.2B.

The current price is ₩7,300 with a P/E ratio of 7.71x and P/B of 0.5x.

ROE is 7.22% and operating margin is 2.56%. Annual revenue is $590.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Il Dong Holdings Co., Ltd. (000230) Stock Forecast 2026 ₩7,300 — Price, Financials & Analyst Targets | Alpha Lenz